Jiajia Huang

Publication Activity (10 Years)

Years Active: 2023-2023
Publications (10 Years): 5

Top Topics

Monoclonal Antibody

Peritoneal Dialysis

Diffuse Large B Cell Lymphoma

Top Venues

Biomarkers in medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Xiaoqing Sun, Jianghua Cao, Peng Sun, Hang Yang, Huan Li, Wenjuan Ma, Xianqiu Wu, Xiaohua He, Jing Li, Zhi-Ming Li, Jiajia Huang
Pretreatment soluble Siglec-5 protein predicts early progression and R-CHOP efficacy in diffuse large B-cell lymphoma. Biomarkers in medicine 17 (3) (2023)
Xiaoqing Sun, Jianghua Cao, Peng Sun, Hang Yang, Huan Li, Wenjuan Ma, Xianqiu Wu, Xiaohua He, Jing Li, Zhi-Ming Li, Jiajia Huang
Pretreatment soluble Siglec-5 protein predicts early progression and R-CHOP efficacy in diffuse large B-cell lymphoma. Biomarkers in medicine 17 (3) (2023)
Xiaoqing Sun, Jianghua Cao, Peng Sun, Hang Yang, Huan Li, Wenjuan Ma, Xianqiu Wu, Xiaohua He, Jing Li, Zhi-Ming Li, Jiajia Huang
Pretreatment soluble Siglec-5 protein predicts early progression and R-CHOP efficacy in diffuse large B-cell lymphoma. Biomarkers in medicine 17 (3) (2023)
Xiaoqing Sun, Jianghua Cao, Peng Sun, Hang Yang, Huan Li, Wenjuan Ma, Xianqiu Wu, Xiaohua He, Jing Li, Zhi-Ming Li, Jiajia Huang
Pretreatment soluble Siglec-5 protein predicts early progression and R-CHOP efficacy in diffuse large B-cell lymphoma. Biomarkers in medicine 17 (3) (2023)
Xiaoqing Sun, Jianghua Cao, Peng Sun, Hang Yang, Huan Li, Wenjuan Ma, Xianqiu Wu, Xiaohua He, Jing Li, Zhi-Ming Li, Jiajia Huang
Pretreatment soluble Siglec-5 protein predicts early progression and R-CHOP efficacy in diffuse large B-cell lymphoma. Biomarkers in medicine (2023)